MD · Pediatrix Medical Group, Inc. · Insider Trading

The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.51 to $26.80 for a weighted average sales price of $26.62. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 115%, 125% and 135% of $22.66 for at least 20 consecutive trading days before the third anniversary of the grant date.

On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.

On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.

The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.

The Reporting Person filed a Form 4 on June 3, 2025, reporting an annual equity award of 194,347 restricted shares granted on June 1, 2025 pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (as further amended and restated on May 7, 2026, the "Plan"), which award, as originally reported, vested as to twenty-five percent (25%) on June 1, 2026, with the remaining portion scheduled to vest twenty-five percent (25%) on June 1, 2027 and fifty percent (50%) on June 1, 2028, in each case subject to the terms of the Plan. Due to the annual award limitations of the Plan, the award was revised so that the remaining fifty percent (50%) of the award that was scheduled to vest on June 1, 2028 was re-granted on June 2, 2026, which portion will still vest on June 1, 2028 in accordance with the original terms of the award, subject to the terms of the Plan and the underlying award agreement.

The Reporting Person filed a Form 4 on June 3, 2025, reporting an annual equity award of 194,347 restricted shares granted on June 1, 2025 pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (as further amended and restated on May 7, 2026, the "Plan"), which award, as originally reported, vested as to twenty-five percent (25%) on June 1, 2026, with the remaining portion scheduled to vest twenty-five percent (25%) on June 1, 2027 and fifty percent (50%) on June 1, 2028, in each case subject to the terms of the Plan. Due to the annual award limitations of the Plan, the award was revised so that the remaining fifty percent (50%) of the award that was scheduled to vest on June 1, 2028 was re-granted on June 2, 2026, which portion will still vest on June 1, 2028 in accordance with the original terms of the award, subject to the terms of the Plan and the underlying award agreement.

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares.

Represents 11,944 restricted shares withheld for payment of taxes upon vesting of shares.

Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares.

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

Represents 19,119 restricted shares withheld for payment of taxes upon vesting of shares.

On May 13, 2026, the reporting person transferred 11,427 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

On May 13, 2026, the reporting person transferred 11,427 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

The reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.

The price in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $23.55 to $23.85 for a weighted average sales price of $23.75. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person and her husband are trustees of the trust that holds the reported securities. Members of the reporting person's immediate family are beneficiaries of the trust.

On May 11, 2026 the reporting person transferred 40,826 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Represents 26,931 shares withheld for payment of taxes upon vesting of shares.

Represents 3,676 restricted shares withheld for payment of taxes upon vesting of shares.

Represents shares awarded pursuant to the satisfaction of performance conditions per the terms of a performance-based restricted share program established on March 1, 2023.

The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $22.00 to $22.62 for a weighted average sales price of $22.41. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.

The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $23.00 to $23.02 for a weighted average sales price of $23.00. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $21.51 to $21.76 for a weighted average sales price of $21.65. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 20, 2025, the reporting person transferred 625 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

On August 19, 2025, the reporting person transferred 54,021 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 8, 2026.

Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date.

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.

On June 10, 2025 the reporting person transferred 10,371 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.

Represents 677 restricted shares withheld for payment of taxes upon vesting of shares.

Represents 6,729 restricted shares withheld for payment of taxes upon vesting of shares.